University of California San Francisco
Give to UCSF
Doug Carlson, UCSF registrar, applies precision to academic record-keeping and also operates scoreboards at major sports venues, blending detailed administrative skills with his passion for sports timing.
Kishan Patel, MD, talks about his experience as a contestant on the latest season of Survivor.
The GRLN policy empowers individuals like Sen, promoting inclusivity and impacting personal lives.
A talk on how breathing affects our mood took first place at this year's Postdoc Slam event, which is held in celebration of National Postdoc Appreciation Week.
A phase II trial for patients with traumatic brain injury (TBI) will aim to break the impasse of 30 years of failed clinical trials for TBI. The study will compare the effects of off-label drugs that have been found to be effective in animal studies.
The UC Board of Regents approved UCSF’s proposal to build a proton therapy facility as part of the redevelopment of the former Dogpatch Power Station, which will join only 45 other sites nationwide and will be the only facility to offer the leading-edge cancer therapy between Los Angeles and Seattle.
UCSF Health is once again recognized by Vizient Inc. as a leader in health care quality.
David Julius and Wendy Yue have discovered a natural mechanism that could help reduce scarring after a spinal cord injury.
Black men are more than twice as likely to die of prostate cancer than their white peers. An innovative community-based UCSF program is increasing screenings among San Francisco's Black communities.
UCSF Health’s new Bayfront Medical Building features interactive art installations including a soundscape mural and a sound sculpture, enhancing the healing environment for patients, families, and healthcare providers.
Powerful electron microscopy and 3D imaging leads scientists to a new discovery showing how the TGF-Beta signaling protein is able to move much more freely than previously thought.
John Clements, MD, whose scientific discoveries helped save millions of newborns around the world from respiratory distress syndrome and whose boundless appetite for learning helped create the interdisciplinary culture at UCSF, has died on Sept. 3, 2024 at the age of 101.
A new study is projecting that the number of people in the U.S. with atrial fibrillation, a common precursor to stroke, is about three times higher than previous estimates. An estimated 35% of people with a-fib will have a stroke.
Since 2020, the Center for Health Equity in Surgery and Anesthesia has used research, education and advocacy to improve access to safe surgical, anesthetic and perioperative care in underserved areas of the U.S. and globally, as well as build a pipeline of care providers from diverse backgrounds.
An extra-long summer surge driven by new variants has prompted the early release of updated COVID-19 vaccines. A UCSF expert tells us what new vaccines could mean for the summer surge, who should get vaccinated, and when/where to get your vaccines.
For the 2024-2025 academic year, UCSF School of Dentistry extends its Community Based Clinical Education to third-year students, previously limited to fourth-year learners.
UCSF is collaborating with the SF Palliative Care Work Group to set up partnerships with local community groups to discuss advance care planning and palliative care. These community groups include churches, senior centers and organizations representing minority populations.
UCSF researchers identify new metabolic biomarkers that could indicate higher risk for Sudden Infant Death Syndrome (SIDS) in infants.
Scientists discover how to drug GTPases, a group of 150 critical enzymes that act like "switches" in cells, which cause a wide variety of diseases such as cancer and Parkinson’s disease when mutated.
Mack Roach, III, MD, FASTRO, has been chosen by the American Society for Radiation Oncology (ASTRO) to receive its 2024 Gold Medal Award. Roach is being recognized with ASTRO’s highest honor for his
UC San Francisco has bestowed its highest honor, the UCSF Medal, to four extraordinary individuals.
A clinical trial that will test three drugs concurrently, and could include more, represents new hope for patients with progressive supranuclear palsy (PSP), an incurable neurodegenerative disorder that usually kills within seven years after symptoms start.
For more than 30 years, UCSF has run a 10-week summer internship program for 40-54 health/life sciences undergraduates. Students are assigned to a lab at UCSF and conduct research, which they present at the end of the program.
The UCSF Prostate Cancer Program will receive about $7 million from the National Cancer Institute to develop new approaches to the prevention, early detection, diagnosis and treatment of prostate cancer.